Clinical Trials

While the rheumatology community often finds itself behind other specialties in head-to-head trials of drugs or drug classes, new data may help clinicians in decision-making, according to a presenter at ACR 2020.

Cancer is a disease of aging, with those aged 70 years or older representing 42% of the total cancer population.

The racial diversity of radiation therapy clinical trials did not appear to match that of the 2018 U.S. Census population, according to study results presented at the virtual ASTRO Annual Meeting.

Participants in rheumatoid arthritis clinical trials who received a placebo exhibited meaningful gains in objective and subjective outcomes, indicating that placebo responses represent more than a psychological effect, researchers noted.

In this video from the Annual Meeting of the American Neurological Association, Justin C. McArthur, MBBS, MPH, discussed the Presidential Symposium, Leveraging Digital Technologies in Neurology, that featured six presentations.

Deirdre J. Cohen, MD, MS, has been appointed director of the gastrointestinal oncology program at Mount Sinai Health System.

In this video, Shigeru Kinoshita, MD, PhD, speaks about the latest results of cell injection therapy using cultured human corneal endothelial cells.

Clinical trials have played a key role in the development of targeted treatments that have improved outcomes for patients with cancer.

American Association for Cancer Research today released its annual Cancer Progress Report, which outlines advances in treatment and prevention and describes how the COVID-19 pandemic has drastically altered cancer research and care.

When it comes to studying treatments for systemic lupus erythematosus, issues such as clinical trial design and patient selection still loom large, according to a speaker at the 2020 Congress of Clinical Rheumatology-East.